CTXR vs NFLX · rev $7.1M vs P/E 25, rev $12.56B
Citius Pharmaceuticals Inc (CTXR) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
CTXR currently screens at market cap $13.4M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the CTXR and NFLX stock pages for the full models.
Not investment advice.